| Literature DB >> 29742608 |
Marcus Unterrainer1, Daniel F Fleischmann, Simon Lindner1, Matthias Brendel1, Rainer Rupprecht2, Joerg C Tonn, Claus Belka, Peter Bartenstein, Maximilian Niyazi, Nathalie L Albert.
Abstract
PET targeting the translocator protein (TSPO) represents an interesting approach for glioma visualization, as TSPO is highly expressed in tumor cells. We present a 32-year-old man with recurrent glioblastoma after multimodal treatment. PET with the novel TSPO ligand F-GE-180 was performed after reirradiation. Here, the previously reirradiated tumor showed a remaining circular TSPO expression. Moreover, cerebrospinal fluid dissemination was detected by a high focal uptake at the right lateral and at the fourth ventricle, whereas only a faint contrast enhancement was present in MRI. This case demonstrated the diagnostic potential of TSPO-PET for glioma imaging by visualizing even minimal disease burden.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29742608 DOI: 10.1097/RLU.0000000000002113
Source DB: PubMed Journal: Clin Nucl Med ISSN: 0363-9762 Impact factor: 7.794